In metastatic NSCLC, elevated GDF15 expression is associated with immune evasion through modulation of the TME, characterized by reduced CD8+ T-cell infiltration, increased Treg cells, and resistance to ICIs [132]. This evidence concerns the gene GDF15 and non-small cell lung carcinoma.